Clinical Trial Update: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of ABP-450 for migraine prevention in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ABP-450

Snippet

Sponsor: AEON Biopharma, Inc. | Conditions: Migraine | Phase 2 | Status: COMPLETED